Diagnostic protocols in Israel for viral hepatitis involve serological screening and molecular PCR testing to measure viral load. Facilities like Sourasky Medical Center (Ichilov) use advanced DNA and RNA sequencing to identify genotypes. This ensures targeted antiviral therapy and precise monitoring of treatment response.
- Serological panels: Antibody tests detect HAV, HBV, and HCV infections during initial screenings.
- Molecular PCR: Quantitative RNA/DNA testing measures viral replication and confirms active viremia.
- Genotype sequencing: Specialized analysis identifies specific viral strains to determine the best medication.
- FibroScan technology: Non-invasive transient elastography assesses liver stiffness and fibrosis without a biopsy.
Bookimed Expert Insight: While many patients focus on initial viral detection, the presence of specialists like Prof. Rafael Bruck, who has over 40 years of experience, highlights the importance of longitudinal monitoring. In large multidisciplinary centers like Sourasky, which serves 400,000+ patients annually, the integration of radioisotope research and metabolic assessments provides a deeper look at liver health than standard blood panels alone.
Patient Consensus: Patients emphasize requesting a FibroScan early to avoid invasive biopsies and establish a baseline. They also note that getting genotype results quickly is vital for starting the correct treatment without delays.
